Catalyst Wire Dossier Catalyst Wire Dossier

Humulin N

insulin isophane (NPH) · Eli Lilly and Company
Drug timelines are a Plus or Pro feature.

45 regulatory and trial events tracked for Humulin N, covering 2007-08-22 to 2022-06-27. Get the full timeline:

Most recent: FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)

See pricing